Featured image for “CLADE expands to the U.S.”
News

CLADE expands to the U.S.

16/06/2025
 /
Lukas Hölzer

We are thrilled to announce a major milestone in our international journey:
Our first CLADE™ MIRA Analyzer has officially been delivered to a customer in the United States!

This marks not only a logistical success but also a strategic step toward deepening our presence in the U.S. biopharma landscape. The delivery highlights the growing demand for advanced, reliable, and intuitive analytical tools that accelerate innovation in life sciences — and we’re proud to be part of that transformation.

The CLADE™ MIRA Analyzer is built for precision, speed, and usability — making it an ideal companion for biopharma teams looking to optimize decision-making and R&D workflows.

A huge thank you to our partners and the teams who made this possible.
We’re excited to see MIRA in action — and to continue growing our footprint across the U.S. and beyond.

Want to learn more about the CLADE™ MIRA Analyzer?

Book a meeting:

DACH, Northern Europe, Eastern Europe, East Coast USA
Southern Europe, Western Europe, UK, Ireland, West Coast USA

First Delivery To USA

Author

Lukas Holzer

Lukas Hölzer

Marketing Manager
Lukas Hölzer is the Marketing Manager at CLADE, where he develops marketing strategies and technical content that showcase the company's innovative bioanalytical technologies. He holds a B.Sc. in Business Administration with a focus on Marketing and specializes in communicating complex scientific and technological concepts to customers, partners, and the life science community. His expertise spans brand positioning, content marketing, digital communications, and B2B technology marketing.

Contact CLADE

Connect with CLADE

Subscribe to the newsletter

Inquire about a product

Request a quote, send us a sample for analysis or other inquiries.

Contact us

Talk to an
expert

Schedule a call with a CLADE expert and discuss your needs.

Schedule call

Follow CLADE on LinkedIn

Join this community to keep updated on latest developments.

Follow us
(opens in a new tab)